Insights

Cutting-edge Therapeutics Parabilis Medicines specializes in developing cutting-edge helical peptide therapeutics targeted at traditionally undruggable proteins. This focus on innovative solutions can be a key selling point to healthcare providers looking for new treatment options for cancer patients.

Financially Stable With over $500 million raised from leading life sciences investors and a revenue in the range of $10 million to $50 million, Parabilis Medicines is well-capitalized for expansion and growth. This financial stability presents an opportunity for sales partnerships with vendors or service providers looking for long-term collaborations.

Extensive Pipeline Parabilis Medicines boasts a diverse pipeline of first-in-class programs targeting proteins relevant to numerous cancers. This broad range of therapeutic offerings can appeal to healthcare institutions seeking comprehensive treatment regimens and may open up opportunities for strategic collaborations or licensing agreements.

Innovative Technology The launch of the Helicon platform, integrating AI, experimental technologies, and data science techniques, showcases Parabilis Medicines' commitment to innovation. This advanced technology stack can be leveraged as a selling point to tech-savvy clients or partners interested in cutting-edge research methodologies.

Industry Leader Among similar companies in biotechnology research, Parabilis Medicines stands out with its dedicated focus on creating extraordinary cancer medicines and its strategic approach to targeting undruggable proteins. Positioning the company as an industry leader can attract sales opportunities from organizations seeking to collaborate with pioneers in cancer therapeutics.

Parabilis Medicines Tech Stack

Parabilis Medicines uses 8 technology products and services including SAS/STAT, MySQL, Dropbox, and more. Explore Parabilis Medicines's tech stack below.

  • SAS/STAT
    Advanced Analytics And Data Science
  • MySQL
    Database
  • Dropbox
    Digital Asset Management
  • Raphael
    Javascript Graphics
  • jQuery Migrate
    Javascript Libraries
  • Microsoft Azure
    Platform As A Service
  • WP Engine
    Platform As A Service
  • PHP
    Programming Languages

Parabilis Medicines's Email Address Formats

Parabilis Medicines uses at least 2 format(s):
Parabilis Medicines Email FormatsExamplePercentage
FLast@fogpharma.comJDoe@fogpharma.com
98%
First.Last@fogpharma.comJohn.Doe@fogpharma.com
1%
FMiddleLast@fogpharma.comJMichaelDoe@fogpharma.com
1%

Frequently Asked Questions

Where is Parabilis Medicines's headquarters located?

Minus sign iconPlus sign icon
Parabilis Medicines's main headquarters is located at 30 Acorn Park Dr Cambridge, MA 02140 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Parabilis Medicines's phone number?

Minus sign iconPlus sign icon
You can contact Parabilis Medicines's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Parabilis Medicines's official website and social media links?

Minus sign iconPlus sign icon
Parabilis Medicines's official website is parabilismed.com and has social profiles on LinkedIn.

How much revenue does Parabilis Medicines generate?

Minus sign iconPlus sign icon
As of December 2024, Parabilis Medicines's annual revenue reached $35M.

What is Parabilis Medicines's SIC code NAICS code?

Minus sign iconPlus sign icon
Parabilis Medicines's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Parabilis Medicines have currently?

Minus sign iconPlus sign icon
As of December 2024, Parabilis Medicines has approximately 160 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief People Officer: K. S.Chief Business Officer: G. M.Chief Data Science Officer: B. A.. Explore Parabilis Medicines's employee directory with LeadIQ.

What industry does Parabilis Medicines belong to?

Minus sign iconPlus sign icon
Parabilis Medicines operates in the Biotechnology Research industry.

What technology does Parabilis Medicines use?

Minus sign iconPlus sign icon
Parabilis Medicines's tech stack includes SAS/STATMySQLDropboxRaphaeljQuery MigrateMicrosoft AzureWP EnginePHP.

What is Parabilis Medicines's email format?

Minus sign iconPlus sign icon
Parabilis Medicines's email format typically follows the pattern of . Find more Parabilis Medicines email formats with LeadIQ.

When was Parabilis Medicines founded?

Minus sign iconPlus sign icon
Parabilis Medicines was founded in 2016.
Parabilis Medicines

Parabilis Medicines

Biotechnology ResearchMassachusetts, United States51-200 Employees

Parabilis Medicines™ is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for people living with cancer. Through our pioneering Helicon™ discovery platform, Parabilis is engineering precisely-tuned, stabilized helical peptide therapeutics that have the potential to unlock a large number of traditionally undruggable targets. FOG-001, our first-in-class TCF-blocking β-catenin inhibitor and lead clinical program, is being evaluated in a Phase 1/2 study for patients with colorectal cancer and other solid tumors and is proof of the applicability of our platform to address undruggable intracellular protein-protein targets. We are additionally advancing a pipeline of other first-in-class programs that target proteins known to be relevant to numerous cancers, but considered intractable with traditional drug modalities. The versatility of the Helicon approach allows for the discovery of multiple targeting mechanisms, including functional protein-protein interaction inhibitors, bifunctional degraders, and radioligand therapeutics. We are headquartered in Cambridge, Mass., and are well-capitalized, with more than $500 million raised to date from leading life sciences investors. For more information, please visit: www.parabilismed.com

Section iconCompany Overview

Headquarters
30 Acorn Park Dr Cambridge, MA 02140 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconFunding & Financials

  • $10M$50M

    Parabilis Medicines's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $10M$50M

    Parabilis Medicines's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.